Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: What else than good science will be needed for the field to become part of Personalized Medicine?"

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 7, 2007, Pages 843-850

  Llerena, Adrián ^a   Michel, Gerd ^b   Jeannesson, Elise ^c   Wong, Steven ^d   Manolopoulos, Vangelis G ^e   Hockett, Richard Dean ^f   Boubekeur, Karima ^g   Siest, Gérard ^h   Beaune, Philippe ⁱ   Haefliger, Carolina ^j   Arnold, Hans Peter ^k   Junien, Claudine ^l   Petrovic, Nenad ^m   Molloy, Roisin ⁿ   Bekers, Otto ^o   Donnelly, Claudine ⁿ   Arens, Hans Juergen ^p   Kaput, Jim ^q   McComb, Joel ^r  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^f Department of Toxicology and Pathology   (United States)

^g F HOFFMANN LA ROCHE LTD   (Switzerland)

^h UNIVERSITÉ DE LORRAINE   (France)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^j EPIGENOMICS AG   (Germany)

^k Epidauros Biotechnologie AG   (Germany)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

^m UNIVERSITY OF SYDNEY   (Australia)

ⁿ Randox Laboratories Ltd   (United Kingdom)

^o MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^p ABBOTT GMBH AND CO KG   (Germany)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r GE HEALTHCARE   (United States)

more..

Author keywords

Education; Industry; Personalized Medicine; Pharmacogenomics; Regulatory aspects

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; ORGANIZATION AND MANAGEMENT; PHARMACOGENOMICS; PRIORITY JOURNAL; SOCIOECONOMICS;

DRUG INDUSTRY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; PHARMACOGENETICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34447274216     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.182     Document Type: Conference Paper

References (10)

1. Frueh F, Gurwitz D. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenetics 2004;5:571-9.
2. Gurwitz D, Manolopoulos VG. Personalized medicine. Comprehensive medicinal chemistry II. Amsterdam: Elsevier. In press.
3. Buchanan A, McPherson E, Brody BA, Califano A, Kahn J, McCullough N, et al. Pharmacogenetics: ethical and regulatory issues in research and clinical practice. Consortium on Pharmacogenetics, 2002.
4. Kirchheiner J, Fuhr U, Brockmoller J. Pharmacogenetics-based therapeutic recommendations. Ready for clinical practice? Nat Rev Drug Discov 2005;4:639-47.
5. Gurwitz D, Lunshof JE, Dedoussis G, Flordellis CS, Fuhr U, Kirchheiner J, et al. Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J 2005;5:221-5.
6. National Academy of Clinical Biochemistry. Laboratory guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice. http://www.aacc.org/NR/rdonlyres/AE772314-08C0-4F75-9895- D40B7181E4F8/0/LMPG_Pharmacogenetics.pdf.
7. Frueh FW, Rudman A, Simon K, Gutman S, Reed C, Dorner AJ. Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop. Pharmacogenomics J 2006;6:296-300.
8. Hinman LM, Huang SM, Hackett J, Koch WH, Love PY, Pennello G, et al. The drug diagnostic co-development concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop. Pharmacogenomics J 2006;6:375-80.
9. Innovative Medicines Initiative, Strategic Research Agenda, http://www.efpia.org/4_pos/SRA.pdf.
10. Institute for Prospective Technological Studies. Pharmacogenetics and Pharmacogenomics: state-of-the-art and potential socio-economic impact in the EU. http://www.jrc.es/home/pages/detail.cfm?prss1387.